Showing 69,221 - 69,240 results of 134,344 for search '(( 2 c decrease ) OR ( 5 ((((step decrease) OR (a decrease))) OR (we decrease)) ))', query time: 2.49s Refine Results
  1. 69221

    DataSheet6_Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.ZIP by Panshuang Qiao (13269444)

    Published 2022
    “…Whether insulin-independent hypoglycemic drug dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, may improve NAFLD keeps unclear. Therefore, 12-week-old male C57BL/6 wild-type and db/db mice were treated with 1 mg/kg dapagliflozin or vehicle for 12 weeks. …”
  2. 69222

    DataSheet13_Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.ZIP by Panshuang Qiao (13269444)

    Published 2022
    “…Whether insulin-independent hypoglycemic drug dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, may improve NAFLD keeps unclear. Therefore, 12-week-old male C57BL/6 wild-type and db/db mice were treated with 1 mg/kg dapagliflozin or vehicle for 12 weeks. …”
  3. 69223

    DataSheet1_Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.xlsx by Panshuang Qiao (13269444)

    Published 2022
    “…Whether insulin-independent hypoglycemic drug dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, may improve NAFLD keeps unclear. Therefore, 12-week-old male C57BL/6 wild-type and db/db mice were treated with 1 mg/kg dapagliflozin or vehicle for 12 weeks. …”
  4. 69224

    DataSheet11_Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.ZIP by Panshuang Qiao (13269444)

    Published 2022
    “…Whether insulin-independent hypoglycemic drug dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, may improve NAFLD keeps unclear. Therefore, 12-week-old male C57BL/6 wild-type and db/db mice were treated with 1 mg/kg dapagliflozin or vehicle for 12 weeks. …”
  5. 69225

    DataSheet4_Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.ZIP by Panshuang Qiao (13269444)

    Published 2022
    “…Whether insulin-independent hypoglycemic drug dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, may improve NAFLD keeps unclear. Therefore, 12-week-old male C57BL/6 wild-type and db/db mice were treated with 1 mg/kg dapagliflozin or vehicle for 12 weeks. …”
  6. 69226

    DataSheet7_Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.ZIP by Panshuang Qiao (13269444)

    Published 2022
    “…Whether insulin-independent hypoglycemic drug dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, may improve NAFLD keeps unclear. Therefore, 12-week-old male C57BL/6 wild-type and db/db mice were treated with 1 mg/kg dapagliflozin or vehicle for 12 weeks. …”
  7. 69227

    DataSheet1_Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.docx by Panshuang Qiao (13269444)

    Published 2022
    “…Whether insulin-independent hypoglycemic drug dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, may improve NAFLD keeps unclear. Therefore, 12-week-old male C57BL/6 wild-type and db/db mice were treated with 1 mg/kg dapagliflozin or vehicle for 12 weeks. …”
  8. 69228
  9. 69229

    Characterization of Cross-Linked Porous Gelatin Carriers and Their Interaction with Corneal Endothelium: Biopolymer Concentration Effect by Jui-Yang Lai (277828)

    Published 2013
    “…The aim of this study was to further investigate the effects of biopolymer concentrations (5–15 wt%) on the characteristic and safety of hydrogel discs fabricated by a simple stirring process combined with freeze-drying method. …”
  10. 69230

    Disrupting autophagy in <i>tti<sup>s450</sup></i> larvae results in the death of IECs and a reduced lifespan. by Yeliz Boglev (280342)

    Published 2013
    “…<p>(A) Western blot analysis of lysates of <i>tti<sup>s450</sup></i> larvae (72 hpf) that had been injected at the 1–4 cell stage with an antisense morpholino oligonucleotide (MO) targeted to the start codon of <i>atg5</i> mRNA reveals decreased levels of LC3II compared to untreated and vehicle controls, both in the presence and absence of chloroquine. …”
  11. 69231
  12. 69232
  13. 69233
  14. 69234
  15. 69235
  16. 69236
  17. 69237

    Using Data-Dependent and -Independent Hybrid Acquisitions for Fast Liquid Chromatography-Based Untargeted Lipidomics by Kanako Tokiyoshi (17736114)

    Published 2024
    “…Untargeted lipidomics using liquid chromatography (LC) coupled with tandem mass spectrometry (MS) is essential for large cohort studies. Using a fast LC gradient of less than 10 min for the rapid screening of lipids decreases the annotation rate, because of the lower coverage of the MS/MS spectra caused by the narrow peak width. …”
  18. 69238

    Using Data-Dependent and -Independent Hybrid Acquisitions for Fast Liquid Chromatography-Based Untargeted Lipidomics by Kanako Tokiyoshi (17736114)

    Published 2024
    “…Untargeted lipidomics using liquid chromatography (LC) coupled with tandem mass spectrometry (MS) is essential for large cohort studies. Using a fast LC gradient of less than 10 min for the rapid screening of lipids decreases the annotation rate, because of the lower coverage of the MS/MS spectra caused by the narrow peak width. …”
  19. 69239

    Using Data-Dependent and -Independent Hybrid Acquisitions for Fast Liquid Chromatography-Based Untargeted Lipidomics by Kanako Tokiyoshi (17736114)

    Published 2024
    “…Untargeted lipidomics using liquid chromatography (LC) coupled with tandem mass spectrometry (MS) is essential for large cohort studies. Using a fast LC gradient of less than 10 min for the rapid screening of lipids decreases the annotation rate, because of the lower coverage of the MS/MS spectra caused by the narrow peak width. …”
  20. 69240

    Using Data-Dependent and -Independent Hybrid Acquisitions for Fast Liquid Chromatography-Based Untargeted Lipidomics by Kanako Tokiyoshi (17736114)

    Published 2024
    “…Untargeted lipidomics using liquid chromatography (LC) coupled with tandem mass spectrometry (MS) is essential for large cohort studies. Using a fast LC gradient of less than 10 min for the rapid screening of lipids decreases the annotation rate, because of the lower coverage of the MS/MS spectra caused by the narrow peak width. …”